Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML

NCT06514261 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

45

Enrollment

NIH

Sponsor class

Stopped Other - Pending amendment for study expansion.

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine
PROCEDURE: Biospecimen Collection
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Buccal Swab
DRUG: Iadademstat
DRUG: Venetoclax

Sponsor

National Cancer Institute (NCI)